Copy

Hi <<First Name>>


Please find your latest copy of the Lab Bulletin Coronavirus (COVID-19) Monthly Update.

This monthly update aims to help keep our readers updated on the latest laboratory products and news for COVID-19 screening and testing.

 

Here's the latest news for you <<First Name>>

INTEGRA Biosciences’ pipettes help to progress infectious disease testing


Cormeum Lab Services, a cutting-edge clinical testing laboratory in Louisiana, is using a range of pipetting solutions from INTEGRA Biosciences to streamline its infectious disease testing workflows. The laboratory acquired additional liquid handling instruments to cope with ever growing demand during the COVID-19 pandemic, and these tools are now supporting expansion of its testing capabilities...



 

INTEGRA Biosciences’ pipettes help clinics to tackle the opioid epidemic


Axis Healthcare, a family-run care facility in Oklahoma, has introduced VOYAGER adjustable tip spacing pipettes from INTEGRA Biosciences into its PCR laboratory workflows. These multichannel pipettes offer the laboratory a straightforward and easy-to-use liquid handling solution to provide accurate and high throughput testing as part of a holistic strategy to support patients in overcoming opioid addiction...



 

Future Insight Prize 2023 Awarded to Khalid Salaita for Early Detection of Pandemics


Merck, has awarded Khalid Salaita, Samuel Candler Dobbs Professor in the Department of Chemistry at Emory University, Atlanta, Georgia, U.S.A., with the Future Insight Prize 2023 worth € 500,000 for research on a pandemic early alert system. Salaita’s group is developing a novel platform technology for automated surveillance and tracing of airborne pathogens in real time...



 

INTEGRA pipetting solutions accelerate crucial viral genomics research


The Center for Emerging Viral Threats (CEVT) in Louisiana, USA, is using INTEGRA Biosciences’ liquid handling solutions for COVID-19 testing and viral genomics studies. These products have streamlined the center’s sample transfer protocols, leading to shorter turnaround times and supporting vital research into the prevention and control of viral respiratory diseases. The CEVT was established in March 2020 to address the urgent testing needs caused by the COVID-19 pandemic...



 

Synexa Life Sciences Joins CEPI in Advancing Global Epidemic Preparedness and Response


Synexa Life Sciences, a specialist biomarker and bioanalysis service provider, announces its membership in the Coalition for Epidemic Preparedness Innovations (CEPI) Central Lab Network (CLN). This strategic partnership represents a significant milestone in Synexa's commitment to global health security and its dedication to fostering collaboration and innovation in epidemic preparedness and response...



 

Illumina's genomic technologies enable better pathogen preparedness and response


Illumina Inc., a global leader in DNA sequencing and array-based technologies, today recognized the progress and impact of genomic technologies on pathogen preparedness and response. Following the boost in sequencing infrastructure and capabilities driven by the COVID-19 pandemic, today genomic technologies are enabling public health agencies and health care systems to better prepare for, and respond to, pathogenic threats...



 

INTEGRA Biosciences’ pipettes help to combat prostate cancer


LynxDx, a Michigan diagnostics laboratory specializing in prostate cancer screening and risk prediction, acquired liquid handling solutions from INTEGRA Biosciences to streamline its sample preparation for high throughput COVID-19 testing. The lab is now in the process of moving these products over to prostate cancer screening, where they are helping to improve result accuracy and turnaround times and, ultimately, support timely diagnosis and treatment...



 

INTEGRA Biosciences’ products offer flexibility in the post-pandemic era


Many laboratories purchased pipetting solutions from INTEGRA Biosciences during the COVID-19 pandemic, to help them cope with the high numbers of samples they were receiving every day for PCR testing. Now the pandemic has been brought somewhat under control, labs are once again able to concentrate their efforts on other vital work, but what has become of those pipetting platforms and devices? A recent survey conducted by INTEGRA provides insights into how these systems are finding new uses...



 

Oxford University scientists


Breakthrough in diagnostics testing enables ‘facial recognition for germs’. Nicolas Shiaelis and Dr Nicole Robb, Oxford University scientists and co-founders of health tech company Pictura Bio, have developed a world-first diagnostic, test powered by artificial intelligence, that can identify known respiratory viruses such as influenza and COVID-19 within five minutes from just one nasal or throat swab...



 

Automata partners with The Francis Crick Institute on integrated automation for genomics


Automata, a leading automation company powering life sciences labs, has announced it is partnering with the Advanced Sequencing Facility (ASF) at The Francis Crick Institute, a world-leading laboratory at the forefront of genomics, to unlock the power of open, integrated automation for genomics sample preparation. Integrated automation will support the Crick’s cutting-edge advanced genomics laboratory with greater walkaway time, R&D flexibility and data quality than ever before...



 

BioGrad to open the UK's second largest biobank facility in Liverpool as part of a


BioGrad is to open the UK's second largest biobank facility in Liverpool, as part of a £7.6m investment into a new headquarters at Wavertree Technology Park. In collaboration with the University of Leicester, BioGrad biobank has already welcomed up to 261,000 samples from the largest long-Covid study in the UK. Further partnerships with Liverpool Women’s Hospital and three private research companies will see BioGrad bank over one million human cell samples banked in its first year...



 

Recent Articles

The Native Antigen Company expands its range of Omicron antigens to include BA.5 variant
Benchtop FT-NMR Applied to SARS-CoV-2 and
How are laboratories tackling misinformation
Merck Invests More than
New Application Note: COVID-19 agent molnupiravir
Benchling Launches the First Complete Solution for RNA R&D to Accelerate mRNA and RNA Therapeutics Development
Infectious disease researchers publish routes to ensure lessons are learned from COVID-19, when using PCR for monkeypox diagnosis
Optimized Lentiviral Vectors to Speed Up Your Research
QIAGEN launches new solutions that significantly accelerate DNA variant detection and RNA sequencing of low-input samples
La Jolla Institute for Immunology Acquires the Carterra LSA Platform to Advance State-of-the-Art Immunological and Infectious Disease Research

 


About Lab Bulletin

Lab Bulletin is a free online resource for scientists and laboratory professionals where you can catch up on the latest news for laboratory products and services. You will also find an extensive directory of laboratory suppliers and manufacturers enabling you to contact companies quickly and easily to request further information.

Lab Bulletin publishes four free monthly newsletters keeping you up-to-date with all of the latest laboratory products and industry news directly to your inbox. In addition to the Coronavirus (COVID-19) Update we have dedicated newsletters for Separation Science, Microscopy & Image Analysis and the Lab Bulletin Monthly Update with a current readership of over 27,000 readers worldwide.

As a subscriber to our Coronavirus (COVID-19) Update, If you would also like to receive a copy of our Separation Science, Microscopy & Image Analysis or the Lab Bulletin monthly newsletter, simply update your
subscription preferences.
 
twitter
Facebook
Website
Email
YouTube
Copyright © 2024 Lab Bulletin, All rights reserved.

Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.